Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

80.77
Delayed Data
As of Jan 17
 +0.36 / +0.45%
Today’s Change
75.21
Today|||52-Week Range
115.00
+0.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$581.0M

Company Description

Heska Corp. engages in the research, development, and manufacture of veterinary products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments. The Core Companion Animal Health segment sells a variety of companion animal health products and services. The Other Vaccines, and Pharmaceuticals and Products segment includes private label vaccine and pharmaceutical production. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Contact Information

Heska Corp.
3760 Rocky Mountain Avenue
Loveland Colorado 80538
P:(970) 493-7272
Investor Relations:

Employees

Shareholders

Mutual fund holders41.66%
Other institutional41.08%
Individual stakeholders19.41%

Top Executives

Kevin S. WilsonPresident, Chief Executive Officer & Director
Jason A. NapolitanoCOO, Secretary & Chief Strategist
Catherine GrassmanChief Accounting Officer, VP & Controller
Nancy WisnewskiEVP-Diagnostic Operations & Product Development
Michael J. McGinleyPresident-Biologicals & Pharmaceuticals